市場調査レポート

商品コード

1546288

移植診断の世界市場の評価：製品・サービス別、技術別、移植タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Transplant Diagnostics Market Assessment, By Product and Services, By Technology, By Transplant Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

出版日: 2024年09月03日
発行: Market Xcel - Markets and Data
ページ情報: 英文 246 Pages
納期: 3～5営業日

カスタマイズ可能

価格

PDF & Excel Printable (Single User License)

USD 4,500 650,880円

レポートPDFを1名の方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Corporate License)

USD 5,700 824,448円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能ですが、企業内部での利用に限定されます。ご利用に際しては、あらかじめ出版社の許諾を得る必要があります。詳細はお問合せください。印刷は可能です。Excelのデータがライセンスに含まれています。

PDF & Excel Printable (Custom Research License)

USD 8,200 1,186,048円

レポートPDFを企業の１カ国の拠点のすべての方がご利用頂けるライセンスです。レポートPDFのパスワード保護はありません。PDF内のテキスト等のコピー＆ペーストは可能です。印刷は無制限で可能です。Excelのデータがライセンスに含まれています。アナリストアワー100時間が含まれており、レポートのカスタマイズなどにご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.64円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の移植診断の市場規模は、2024年～2031年の予測期間中に8.05％のCAGRで拡大し、2023年の50億7,522万米ドルから2031年には94億2,873万米ドルに成長すると予測されています。移植診断製品・サービスの市場は、移植手術件数の増加とともに大きく成長しています。移植診断市場は予測期間中、顕著なペースで成長し続けると予想されます。

移植診断には、潜在的な臓器ドナーと臓器レシピエントの評価、ドナーとレシピエントのマッチング、移植臓器に拒絶反応の兆候がないかのモニタリングに使用される様々な検査や手順が含まれます。同市場は、臓器移植に対する需要の高まりによって大きな牽引力となっています。疾病負担の増加とそれに伴う臓器移植の必要性は、人々の臓器移植に対する意識の高まりと相まって、移植件数の増加を牽引しています。移植手術の増加に伴い、規制上の制約から移植用診断薬の需要も増加すると予想されます。市場参入企業が提携、合併、革新的な製品の発売などの戦術を通じて市場成長を高めるために積極的に参加していることが、移植診断市場をさらに強化しています。

毎年行われる臓器移植手術は近年大幅に増加し、過去最高を記録しています。この成長は、臓器提供に対する意識の高まりによる死亡臓器提供者と生体臓器提供者の両方の増加、転帰を改善した移植医療の進歩、全国的な臓器提供と移植システムの確立、国民の意識の高まり、潜在的提供者の自発的登録など、いくつかの重要な要因によってもたらされています。こうした動きの結果、米国の臓器調達・移植ネットワーク（OPTN）によると、2023年には46,000件以上の臓器移植が行われ、前年の2022年から8.7％の増加を記録しました。利用可能な臓器のプールが拡大したことで、不特定多数の患者を含むより多くの患者が、必要な救命移植を受けられるようになっています。移植手術の増加に伴い、移植関連診断薬の需要も増加すると予想されます。移植診断は移植手術の重要な一部だからです。

当レポートでは、世界の移植診断市場について調査し、市場の概要とともに、製品・サービス別、技術別、移植タイプ別、用途別、エンドユーザー別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

市場リーダー上位5社の競合マトリックス
上位5社のSWOT分析
主要企業上位10社の情勢
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- Illumina Inc.
- Immucor Transplant Diagnostics Inc.
- Thermo Fisher Scientific Inc.
- CareDx, Inc.
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories Inc.
- BioMerieux S.A.
- QIAGEN N.V.

第22章戦略的提言

第23章お問い合わせと免責事項

図表

List of Tables

Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

Figure 1. Global Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 2. Global Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 3. Global Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 4. Global Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 5. Global Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 6. Global Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 7. Global Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 8. Global Transplant Diagnostics Market Share (%), By Region, 2017-2031F
Figure 9. North America Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 10. North America Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 11. North America Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 12. North America Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 13. North America Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 14. North America Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 15. North America Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 16. North America Transplant Diagnostics Market Share (%), By Country, 2017-2031F
Figure 17. United States Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 18. United States Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 19. United States Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 20. United States Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 21. United States Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 22. United States Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 23. United States Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 24. Canada Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 25. Canada Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 26. Canada Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 27. Canada Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 28. Canada Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 29. Canada Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 30. Canada Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 31. Mexico Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 32. Mexico Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 33. Mexico Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 34. Mexico Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 35. Mexico Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 36. Mexico Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 37. Mexico Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 38. Europe Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 39. Europe Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 40. Europe Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 41. Europe Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 42. Europe Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 43. Europe Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 44. Europe Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 45. Europe Transplant Diagnostics Market Share (%), By Country, 2017-2031F
Figure 46. Germany Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 47. Germany Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 48. Germany Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 49. Germany Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 50. Germany Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 51. Germany Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 52. Germany Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 53. France Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 54. France Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 55. France Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 56. France Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 57. France Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 58. France Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 59. France Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 60. Italy Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 61. Italy Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 62. Italy Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 63. Italy Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 64. Italy Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 65. Italy Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 66. Italy Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 67. United Kingdom Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 68. United Kingdom Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 69. United Kingdom Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 70. United Kingdom Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 71. United Kingdom Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 72. United Kingdom Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 73. United Kingdom Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 74. Russia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 75. Russia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 76. Russia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 77. Russia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 78. Russia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 79. Russia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 80. Russia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 81. Netherlands Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 82. Netherlands Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 83. Netherlands Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 84. Netherlands Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 85. Netherlands Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 86. Netherlands Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 87. Netherlands Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 88. Spain Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 89. Spain Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 90. Spain Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 91. Spain Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 92. Spain Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 93. Spain Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 94. Spain Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 95. Turkey Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 96. Turkey Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 97. Turkey Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 98. Turkey Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 99. Turkey Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 100. Turkey Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 101. Turkey Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 102. Poland Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 103. Poland Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 104. Poland Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 105. Poland Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 106. Poland Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 107. Poland Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 108. Poland Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 109. South America Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 110. South America Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 111. South America Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 112. South America Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 113. South America Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 114. South America Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 115. South America Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 116. South America Transplant Diagnostics Market Share (%), By Country, 2017-2031F
Figure 117. Brazil Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 118. Brazil Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 119. Brazil Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 120. Brazil Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 121. Brazil Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 122. Brazil Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 123. Brazil Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 124. Argentina Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 125. Argentina Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 126. Argentina Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 127. Argentina Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 128. Argentina Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 129. Argentina Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 130. Argentina Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 131. Asia-Pacific Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 132. Asia-Pacific Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 133. Asia-Pacific Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 134. Asia-Pacific Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 135. Asia-Pacific Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 136. Asia-Pacific Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 137. Asia- Pacific Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 138. Asia-Pacific Transplant Diagnostics Market Share (%), By Country, 2017-2031F
Figure 139. India Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 140. India Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 141. India Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 142. India Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 143. India Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 144. India Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 145. India Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 146. China Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 147. China Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 148. China Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 149. China Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 150. China Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 151. China Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 152. China Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 153. Japan Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 154. Japan Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 155. Japan Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 156. Japan Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 157. Japan Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 158. Japan Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 159. Japan Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 160. Australia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 161. Australia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 162. Australia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 163. Australia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 164. Australia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 165. Australia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 166. Australia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 167. Vietnam Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 168. Vietnam Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 169. Vietnam Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 170. Vietnam Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 171. Vietnam Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 172. Vietnam Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 173. Vietnam Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 174. South Korea Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 175. South Korea Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 176. South Korea Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 177. South Korea Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 178. South Korea Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 179. South Korea Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 180. South Korea Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 181. Indonesia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 182. Indonesia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 183. Indonesia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 184. Indonesia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 185. Indonesia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 186. Indonesia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 187. Indonesia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 188. Philippines Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 189. Philippines Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 190. Philippines Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 191. Philippines Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 192. Philippines Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 193. Philippines Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 194. Philippines Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 195. Middle East & Africa Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 196. Middle East & Africa Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 197. Middle East & Africa Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 198. Middle East & Africa Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 199. Middle East & Africa Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 200. Middle East & Africa Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 201. Middle East & Africa Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 202. Middle East & Africa Transplant Diagnostics Market Share (%), By Country, 2017-2031F
Figure 203. Saudi Arabia Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 204. Saudi Arabia Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 205. Saudi Arabia Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 206. Saudi Arabia Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 207. Saudi Arabia Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 208. Saudi Arabia Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 209. Saudi Arabia Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 210. UAE Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 211. UAE Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 212. UAE Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 213. UAE Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 214. UAE Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 215. UAE Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 216. UAE Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 217. South Africa Transplant Diagnostics Market, By Value, In USD Million, 2017-2031F
Figure 218. South Africa Transplant Diagnostics Market, By Volume, In Number of Transplants Performed, 2017-2031F
Figure 219. South Africa Transplant Diagnostics Market Share (%), By Product and Services, 2017-2031F
Figure 220. South Africa Transplant Diagnostics Market Share (%), By Technology, 2017-2031F
Figure 221. South Africa Transplant Diagnostics Market Share (%), By Transplant Type, 2017-2031F
Figure 222. South Africa Transplant Diagnostics Market Share (%), By Application, 2017-2031F
Figure 223. South Africa Transplant Diagnostics Market Share (%), By End-user, 2017-2031F
Figure 224. By Product and Services Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 225. By Technology Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 226. By Transplant Type Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 227. By Application Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 228. By End-user Map-Market Size (USD Million) & Growth Rate (%), 2023
Figure 229. By Region Map-Market Size (USD Million) & Growth Rate (%), 2023

Product Code: MX11838

Global transplant diagnostics market is projected to witness a CAGR of 8.05% during the forecast period 2024-2031, growing from USD 5075.22 million in 2023 to USD 9428.73 million in 2031. The market for transplant diagnostic products and services is thriving significantly with the rising number of transplant procedures. The transplant diagnostics market is anticipated to keep growing at a notable pace during the forecast period.

Transplant diagnostics involves various tests and procedures used to assess potential organ donors and organ recipients, match donors to recipients, and monitor transplanted organs for any signs of rejection. The market is gaining significant traction due to the rising demand for organ transplants. The rising disease burden and subsequent need for organ transplants, combined with rising awareness about organ transplants among people, drives the rising number of transplants. With an increase in transplant procedures, the demand for transplant diagnostics is also anticipated to increase due to regulatory constraints. The active participation of market players to enhance market growth through tactics like collaborations, mergers, and innovative product launches further strengthens the market for transplant diagnostics. For instance, in September 2023, Hungarian molecular diagnostics firm Omixon Inc. introduced a new single-locus human leukocyte antigen (HLA) typing kit called NanoType Mono, based on nanopore sequencing. Similarly, Dutch company Genome Diagnostics B.V., a division of Eurobio Scientific SA, launched another product called NGS-Turbo, an assay designed for high-resolution HLA typing using Oxford Nanopore Technologies platforms.

High Demand for Organ Transplants

The organ transplant procedures performed annually have significantly increased in recent years, reaching new record highs. This growth is driven by several key factors, including a rise in both deceased and living organ donors due to growing awareness about organ donations, advances in transplant medicine that have improved outcomes, the establishment of a national organ donation and transplant system, heightened public awareness and voluntary registration of potential donors. As a result of these developments, according to the Organ Procurement and Transplantation Network (OPTN) of the United States, over 46,000 organ transplants were performed in 2023, recording an 8.7% increase from the prior year 2022. The expanding pool of available organs has allowed more patients, including underrepresented groups, to receive the lifesaving transplants they need. As the number of transplant procedures increases, the demand for transplant-associated diagnostics is anticipated to increase too, as transplant diagnostics is a crucial part of transplant procedures.

Technological Advancements Drive Market Growth

Artificial intelligence (AI) and machine learning have revolutionized transplant diagnostics by enabling the development of AI-powered diagnostic models that can analyze digitized biopsy specimens, improve assessments of transplanted organs, and reduce variability among diagnoses. Advanced imaging techniques provide detailed information about organ function and structure, improving early diagnosis of complications. Innovations in organ preservation, ventricular assist devices, artificial hearts, gene editing, customized organs, and robotic technology have significantly improved transplant outcomes and reduced patient complications. Market players have come up with several AI-based solutions for transplant diagnostics. For instance, in May 2024, Thermo Fisher Scientific Inc. launched a new CXCL10 testing service to aid in the management of kidney transplant patients. The non-invasive urine test can detect the CXCL10 chemokine, which may provide valuable information faster than currently used tests and help identify early signs of kidney transplant rejection. The test is expected to make post-transplant care more convenient and less invasive for the nearly 250,000 Americans living with a kidney transplant. According to Thermo Fisher, this lower-cost, non-invasive testing option can expand access to care and improve patient adherence, as the sample can be collected at any local clinic.

Dominance of Solid Organ Transplant Segment in Transplant Diagnostics Market

Solid organ transplants are the most common type of transplant procedure performed over a long period of time; while other transplant methods like stem cell and soft tissue transplants evolved in the last few decades at the commercial level, the solid organ transplant segment is anticipated to hold the largest share in the market. The kidney, liver, and skin are the most common organs to be transplanted. For instance, according to the Organ Procurement and Transplantation Network (OPTN) of the United States, 10,000 liver transplants and 3,000 lung transplants have been performed in 2023, within the United States, while the total number of organ transplants is above 46,000, in the same place only around 23,000 Hematopoietic Stem Cell Transplantation (HSCT), i.e., stem cell type of transplant were performed in the United States.

North America Dominates Transplant Diagnostics Market

North America is anticipated to lead in the transplant diagnostics market during the forecasted period owing to a highly aware population who knows about organ donation and transplantation very well. The United States and Canada are two major North American countries with well-structured healthcare systems and government initiatives to promote organ transplants. The United States contributes a significant share of revenue in the global market due to the high cost of procedures. The United States reached the milestone of 1 million organ transplants in 2022, and the number is still rising. As per the International Registry on Organ Donation and Transplantation, the United States transplant system saves more lives than any other country. The United States leads with the highest rates of deceased donors and kidney and liver transplants from deceased donors.

Future Market Scenario (2024-2031F)

Immunogenetics and pharmacogenomics are revolutionizing transplant diagnostics by enabling more precise donor matching, personalized immunosuppression dosing based on genetic factors, non-invasive rejection monitoring techniques, and targeted cellular therapies, leading to improved outcomes and reduced complications for transplant recipients. These advancements are transforming the future of transplant care through personalized, data-driven approaches that leverage genetic insights. Key players in the market are also aligning themselves with this evolving technology through the launch of new products.

For instance, in June 2024, Omixon Inc., announced the launch of HolograFT One, a research-use-only kit and software designed for post-transplant monitoring using donor-derived cell-free DNA (dd-cfDNA). HolograFT One enables researchers to accurately quantify dd-cfDNA levels, which serve as a biomarker for detecting rejection in solid organ transplant recipients. This innovative solution combines a user-friendly sample preparation kit with advanced data analysis software, providing researchers with a comprehensive tool to monitor transplant health and potentially improve patient outcomes.

Key Players Landscape and Outlook

Becton Dickinson and Company, Bio-Rad Laboratories Inc., Illumina Inc., Immucor Transplant Diagnostics Inc., Thermo Fisher Scientific Inc., CareDx, Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories Inc., BioMerieux S.A., QIAGEN N.V. are some of the leading players in the transplant diagnostics market. The market witnessed some substantial market deals like mergers and collaborations to expand the market share of key players.

In May 2024, Werfen, S.A., announced the acquisition of Omixon Inc., a privately held company focused on Next Generation Sequencing (NGS) technologies for transplant diagnostics. The transaction, valued at approximately USD 25 million, is expected to be completed in 2024 and will allow Werfen to expand its portfolio of transplant diagnostics solutions. Omixon's expertise in bioinformatics, software engineering, and molecular biology will complement Werfen's strengths in transplant diagnostics, creating an opportunity to advance transplant diagnostics globally.

In April 2024, Eurofins, a global leader in bioanalytical testing, expanded its offerings in renal and transplant testing in the United States by acquiring Ascend Clinical LLC. This acquisition enhances Eurofins' capabilities in providing comprehensive testing solutions for kidney health and transplant patients.

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Transplant Diagnostics Market Outlook, 2017-2031F

4.1. Market Size Analysis & Forecast
- 4.1.1. By Value
- 4.1.2. By Volume
4.2. Market Share Analysis & Forecast
- 4.2.1. By Product and Services
  - 4.2.1.1. Reagents and Consumables
  - 4.2.1.2. Instruments
  - 4.2.1.3. Software and Services
- 4.2.2. By Technology
  - 4.2.2.1. Molecular Assay
    - 4.2.2.1.1. PCR-Based Molecular Assay
    - 4.2.2.1.2. Sequence-Based Molecular Assay
  - 4.2.2.2. Non-Molecular Assay
- 4.2.3. By Transplant Type
  - 4.2.3.1. Solid Organ
  - 4.2.3.2. Stem Cell
  - 4.2.3.3. Soft Tissue
  - 4.2.3.4. Bone Marrow
- 4.2.4. By Application
  - 4.2.4.1. Diagnostics
    - 4.2.4.1.1. Pre-Transplant
    - 4.2.4.1.2. Post-Transplant
  - 4.2.4.2. Research
- 4.2.5. By End-user
  - 4.2.5.1. Hospitals and Transplant Centers
  - 4.2.5.2. Research Laboratories and Academic Institutions
  - 4.2.5.3. Independent Reference Laboratories
- 4.2.6. By Region
  - 4.2.6.1. North America
  - 4.2.6.2. Europe
  - 4.2.6.3. Asia-Pacific
  - 4.2.6.4. South America
  - 4.2.6.5. Middle East and Africa
- 4.2.7. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
4.3. Market Map Analysis, 2023
- 4.3.1. By Product and Services
- 4.3.2. By Technology
- 4.3.3. By Transplant Type
- 4.3.4. By Application
- 4.3.5. By End-user
- 4.3.6. By Region

5. North America Transplant Diagnostics Market Outlook, 2017-2031F*

5.1. Market Size Analysis & Forecast
- 5.1.1. By Value
- 5.1.2. By Volume
5.2. Market Share Analysis & Forecast
- 5.2.1. By Product and Services
  - 5.2.1.1. Reagents and Consumables
  - 5.2.1.2. Instruments
  - 5.2.1.3. Software and Services
- 5.2.2. By Technology
  - 5.2.2.1. Molecular Assay
    - 5.2.2.1.1. PCR-Based Molecular Assay
    - 5.2.2.1.2. Sequence-Based Molecular Assay
  - 5.2.2.2. Non-Molecular Assay
- 5.2.3. By Transplant Type
  - 5.2.3.1. Solid Organ
  - 5.2.3.2. Stem Cell
  - 5.2.3.3. Soft Tissue
  - 5.2.3.4. Bone Marrow
- 5.2.4. By Application
  - 5.2.4.1. Diagnostics
    - 5.2.4.1.1. Pre-Transplant
    - 5.2.4.1.2. Post-Transplant
  - 5.2.4.2. Research
- 5.2.5. By End-user
  - 5.2.5.1. Hospitals and Transplant Centers
  - 5.2.5.2. Research Laboratories and Academic Institutions
  - 5.2.5.3. Independent Reference Laboratories
- 5.2.6. By Country Share
  - 5.2.6.1. United States
  - 5.2.6.2. Canada
  - 5.2.6.3. Mexico
5.3. Country Market Assessment
- 5.3.1. United States Transplant Diagnostics Market Outlook, 2017-2031F*
  - 5.3.1.1. Market Size Analysis & Forecast
    - 5.3.1.1.1. By Value
    - 5.3.1.1.2. By Volume
  - 5.3.1.2. Market Share Analysis & Forecast
    - 5.3.1.2.1. By Product and Services
      - 5.3.1.2.1.1. Reagents and Consumables
      - 5.3.1.2.1.2. Instruments
      - 5.3.1.2.1.3. Software and Services
    - 5.3.1.2.2. By Technology
      - 5.3.1.2.2.1. Molecular Assay
      - 5.3.1.2.2.1.1. PCR-Based Molecular Assay
      - 5.3.1.2.2.1.2. Sequence-Based Molecular Assay
      - 5.3.1.2.2.2. Non-Molecular Assay
    - 5.3.1.2.3. By Transplant Type
      - 5.3.1.2.3.1. Solid Organ
      - 5.3.1.2.3.2. Stem Cell
      - 5.3.1.2.3.3. Soft Tissue
      - 5.3.1.2.3.4. Bone Marrow
    - 5.3.1.2.4. By Application
      - 5.3.1.2.4.1. Diagnostics
      - 5.3.1.2.4.1.1. Pre-Transplant
      - 5.3.1.2.4.1.2. Post-Transplant
      - 5.3.1.2.4.2. Research
    - 5.3.1.2.5. By End-user
      - 5.3.1.2.5.1. Hospitals and Transplant Centers
      - 5.3.1.2.5.2. Research Laboratories and Academic Institutions
      - 5.3.1.2.5.3. Independent Reference Laboratories
- 5.3.2. Canada
- 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Transplant Diagnostics Market Outlook, 2017-2031F

6.1.1. Germany
6.1.2. France
6.1.3. Italy
6.1.4. United Kingdom
6.1.5. Russia
6.1.6. Netherlands
6.1.7. Spain
6.1.8. Poland

7. Asia-Pacific Transplant Diagnostics Market Outlook, 2017-2031F

7.1.1. India
7.1.2. China
7.1.3. Japan
7.1.4. Australia
7.1.5. Vietnam
7.1.6. South Korea
7.1.7. Indonesia
7.1.8. Philippines

8. South America Transplant Diagnostics Market Outlook, 2017-2031F

8.1.1. Brazil
8.1.2. Argentina

9. Middle East and Africa Transplant Diagnostics Market Outlook, 2017-2031F

9.1.1. Saudi Arabia
9.1.2. UAE
9.1.3. South Africa
9.1.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

16.1. Market Drivers
16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

18.1. Clinical Trials
18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

21.1. Competition Matrix of Top 5 Market Leaders
21.2. SWOT Analysis for Top 5 Players
21.3. Key Players Landscape for Top 10 Market Players
- 21.3.1. Becton Dickinson and Company
  - 21.3.1.1. Company Details
  - 21.3.1.2. Key Management Personnel
  - 21.3.1.3. Products and Services
  - 21.3.1.4. Financials (As Reported)
  - 21.3.1.5. Key Market Focus and Geographical Presence
  - 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
- 21.3.2. Bio-Rad Laboratories Inc.
- 21.3.3. Illumina Inc.
- 21.3.4. Immucor Transplant Diagnostics Inc.
- 21.3.5. Thermo Fisher Scientific Inc.
- 21.3.6. CareDx, Inc.
- 21.3.7. F. Hoffmann-La Roche Ltd
- 21.3.8. Abbott Laboratories Inc.
- 21.3.9. BioMerieux S.A.
- 21.3.10. QIAGEN N.V.

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

移植診断の世界市場の評価：製品・サービス別、技術別、移植タイプ別、用途別、エンドユーザー別、地域別、機会、予測、2017年～2031年

Transplant Diagnostics Market Assessment, By Product and Services, By Technology, By Transplant Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F

目次

第1章 プロジェクトの範囲と定義

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 世界の移植診断市場の見通し、2017年～2031年

第5章 北米の移植診断市場の見通し、2017年～2031年

第6章 欧州の移植診断市場の見通し、2017年～2031年

第7章 アジア太平洋の移植診断市場の見通し、2017年～2031年

第8章 南米の移植診断市場の見通し、2017年～2031年

第9章 中東・アフリカの移植診断市場の見通し、2017年～2031年

第10章 需要供給分析

第11章 輸出入の分析

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

第14章 PESTLE分析

第15章 価格分析

第16章 市場力学

第17章 市場の動向と発展

第18章 規制枠組みとイノベーション

第19章 特許の情勢

第20章 ケーススタディ

第21章 競合情勢

第22章 戦略的提言

第23章 お問い合わせと免責事項

List of Tables

List of Figures

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Transplant Diagnostics Market Outlook, 2017-2031F

5. North America Transplant Diagnostics Market Outlook, 2017-2031F*

6. Europe Transplant Diagnostics Market Outlook, 2017-2031F

7. Asia-Pacific Transplant Diagnostics Market Outlook, 2017-2031F

8. South America Transplant Diagnostics Market Outlook, 2017-2031F

9. Middle East and Africa Transplant Diagnostics Market Outlook, 2017-2031F

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

17. Market Trends and Developments

18. Regulatory Framework and Innovation

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

22. Strategic Recommendations

23. About Us and Disclaimer

第1章プロジェクトの範囲と定義

第2章調査手法

第3章エグゼクティブサマリー

第4章世界の移植診断市場の見通し、2017年～2031年

第5章北米の移植診断市場の見通し、2017年～2031年

第6章欧州の移植診断市場の見通し、2017年～2031年

第7章アジア太平洋の移植診断市場の見通し、2017年～2031年

第8章南米の移植診断市場の見通し、2017年～2031年

第9章中東・アフリカの移植診断市場の見通し、2017年～2031年

第10章需要供給分析

第11章輸出入の分析

第12章バリューチェーン分析

第13章ポーターのファイブフォース分析

第15章価格分析

第16章市場力学

第17章市場の動向と発展

第18章規制枠組みとイノベーション

第19章特許の情勢

第20章ケーススタディ

第21章競合情勢

第22章戦略的提言

第23章お問い合わせと免責事項